THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Hillsdale Investment Management Inc.'s Holding History (CIK: 0001368465)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 308,600 Value ($000) $5,774 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 310,700 Value ($000) $4,536 Avg Close $12.64 Range $10.82 - $14.87

Q2 2020

Shares 30,700 Value ($000) $644 Avg Close $25.69 Range $20.17 - $31.35

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	308,600	$5,774	$16.59	$13.50 - $20.33
Q3 2025	310,700	$4,536	$12.64	$10.82 - $14.87
Q2 2020	30,700	$644	$25.69	$20.17 - $31.35